Literature DB >> 1621315

Mycobacterium bovis vertebral osteomyelitis and psoas abscess after intravesical BCG therapy for bladder carcinoma.

D S Katz1, H Wogalter, R F D'Esposito, B A Cunha.   

Abstract

Systemic complications of intravesicular BCG for bladder carcinoma are uncommon, and include fever, pneumonia, hepatitis, arthralgias, or skin rash. Local complications of BCG therapy for bladder cancer include cystitis, prostatitis, epididymo-orchitis, granulomatous lymphadenitis, or ureteral obstruction. We believe this is the first case of Mycobacterium bovis vertebral osteomyelitis and psoas abscess complicating intravesicular BCG therapy for bladder carcinoma.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1621315     DOI： 10.1016/0090-4295(92)90439-4

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  11 in total

1.  A case of Pott's disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer.

Authors:  Colin B Josephson; Saleh Al-Azri; Daniel J Smyth; David Haase; B Lynn Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.

Authors:  I S Aljada; J K Crane; N Corriere; D G Wagle; D Amsterdam
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 3.  Bacterial, fungal, parasitic, and viral myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  Combined infection of vertebroplasty and aortic graft after intravesical BCG treatment.

Authors:  Bart Santbergen; P H W E Vriens; W C M de Lange; M E E Van Kasteren
Journal:  BMJ Case Rep       Date:  2013-01-25

5.  Pancreatic and psoas abscesses as a late complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer: a case report and review of the literature.

Authors:  Miguel Alvarez-Múgica; Jesús M Fernández Gómez; Verónica Bulnes Vázquez; Antonio Jalón Monzón; José M Fernández Rodríguez; Laura Rodríguez Robles
Journal:  J Med Case Rep       Date:  2009-09-15

6.  Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy.

Authors:  Sami Obaid; Alexander G Weil; Ralph Rahme; Cathy Gendron; Daniel Shedid
Journal:  Surg Neurol Int       Date:  2011-11-14

7.  Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer.

Authors:  Charles E Mackel; Shane M Burke; Taylor Huhta; Ron Riesenburger; Simcha J Weller
Journal:  Cureus       Date:  2016-03-26

Review 8.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

9.  Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer.

Authors:  Masashi Miyazaki; Toyomi Yoshiiwa; Toshinobu Ishihara; Masanori Kawano; Hiroshi Tsumura
Journal:  Case Rep Orthop       Date:  2016-05-30

10.  Mycobacterium bovis Osteomyelitis of the Thoracic Spine Mimicking a Metastatic Lytic Lesion in a Patient Exposed to Intravesicular Bacille Calmette-Guérin Treatment.

Authors:  Jessica R Newman; Lisa A Clough; Fernando Merino
Journal:  Urol Case Rep       Date:  2014-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.